Mindray Announced Shareholder Resolutions post Annual General Meeting 2012
SHENZHEN, China, Dec. 31, 2012
SHENZHEN, China, Dec. 31, 2012 /PRNewswire-FirstCall/ -- Mindray Medical
International Limited ("Mindray", NYSE: MR), a leading developer, manufacturer
and marketer of medical devices worldwide, today announced shareholder
resolutions adopted at its annual general meeting of shareholders held in Hong
Kong on December 28,2012.
At the meeting, Mindray shareholders approved the re-election of incumbent
directors Xu Hang, Ronald Ede and Chen Qingtai, each to serve a three-year
In addition, Mindray shareholders ratified the appointment of
PricewaterhouseCoopers as the Company's independent registered public
accounting firm for the fiscal year ending December 31, 2012.
We are a leading developer, manufacturer and marketer of medical devices
worldwide. We maintain our global headquarters inShenzhen, China, U.S.
headquarters inMahwah, New Jerseyand multiple sales offices in major
international markets. From our main manufacturing and engineering base
inChina, we supply through our worldwide distribution network a broad range
of products across three primary business segments, namely patient monitoring
and life support, in-vitro diagnostic, and medical imaging systems. For more
information, please visithttp://ir.mindray.com.
For investor and media inquiries please contact:
In the U.S:
Western Bridge, LLC
Mindray Medical International Limited
SOURCE Mindray Medical International Limited
Press spacebar to pause and continue. Press esc to stop.